Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6
CNS drug design based on principles of blood-brain barrier transport
Once reconstituted in DMSO, it should be aliquoted and stored at -20C to prevent freeze-thaw degradation
When administering a GHK-Cu topical product to a target area, apply either as directed by the manufacturer or in accordance with relevant guidelines
The primary mechanisms of action include: Enhancing glucose-dependent insulin secretion from pancreatic beta cells, which helps lower blood glucose levels when they are elevated Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production [1] [2] Slowing gastric emptying , which moderates the rate at which nutrients enter the bloodstream Promoting satiety through central nervous system pathways, leading to reduced caloric intake [1] [2] These medications are peptide-based (and one fusion protein) and are temperature sensitive
Gastroenterology 77 (4), 761767
